3rd Quarter Report of 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
3rd Quarter Report of 2023
Filed with SSE ·
3rd Quarter Report of 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Jiangsu gdk Biotechnology Co., Ltd. on 6ix
Later from Jiangsu gdk Biotechnology
- Announcement on Follow-up Progress in Temporary Suspension of Production
- Announcement on Resignation of Independent Director
- Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season
- Announcement on Resignation and Appointment of Senior Management Members
- Announcement on Freezing over Some Funds in Special Account for Raised Funds
Follow Jiangsu gdk Biotechnology into a list and get an email when it puts out news.
Follow Jiangsu gdk Biotechnology